Epitomee Financial Statements From 2010 to 2024

EPIT Stock   929.20  17.20  1.82%   
Epitomee Medical financial statements provide useful quarterly and yearly information to potential Epitomee Medical investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Epitomee Medical financial statements helps investors assess Epitomee Medical's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Epitomee Medical's valuation are summarized below:
Epitomee Medical does not presently have any fundamental signals for analysis.
Check Epitomee Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Epitomee Medical's main balance sheet or income statement drivers, such as , as well as many indicators such as . Epitomee financial statements analysis is a perfect complement when working with Epitomee Medical Valuation or Volatility modules.
  
This module can also supplement various Epitomee Medical Technical models . Check out the analysis of Epitomee Medical Correlation against competitors.

Epitomee Medical Company Shares Owned By Institutions Analysis

Epitomee Medical's Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.

Shares Held by Institutions

 = 

Funds and Banks

+

Firms

More About Shares Owned By Institutions | All Equity Analysis

Current Epitomee Medical Shares Owned By Institutions

    
  20.28 %  
Most of Epitomee Medical's fundamental indicators, such as Shares Owned By Institutions, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Epitomee Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition

Based on the latest financial disclosure, 20.28% of Epitomee Medical are shares owned by institutions. This is 54.57% lower than that of the Healthcare sector and 63.39% lower than that of the Medical Devices industry. The shares owned by institutions for all Israel stocks is 48.28% higher than that of the company.

Epitomee Medical Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Epitomee Medical's current stock value. Our valuation model uses many indicators to compare Epitomee Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Epitomee Medical competition to find correlations between indicators driving Epitomee Medical's intrinsic value. More Info.
Epitomee Medical is rated as one of the top companies in current valuation category among its peers. It also is one of the top stocks in shares outstanding category among its peers creating about  0.09  of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Epitomee Medical is roughly  11.46 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Epitomee Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Epitomee Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Epitomee Medical Financial Statements

Epitomee Medical stakeholders use historical fundamental indicators, such as Epitomee Medical's revenue or net income, to determine how well the company is positioned to perform in the future. Although Epitomee Medical investors may analyze each financial statement separately, they are all interrelated. For example, changes in Epitomee Medical's assets and liabilities are reflected in the revenues and expenses on Epitomee Medical's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Epitomee Medical. Please read more on our technical analysis and fundamental analysis pages.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Epitomee Stock

Epitomee Medical financial ratios help investors to determine whether Epitomee Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Epitomee with respect to the benefits of owning Epitomee Medical security.